StockNews.AI
DNA
StockNews.AI
182 days

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

1. Ginkgo Bioworks plans Q&A session on Feb 25, 2025. 2. Presentation to review Q4 and full year 2024 performance. 3. Details will be available on Ginkgo's investor relations website. 4. Ginkgo specializes in cell programming and biosecurity solutions. 5. Replay of the presentation will also be accessible online.

-11.41%Current Return
VS
+0.51%S&P 500
$14.7302/18 08:07 AM EDTEvent Start

$13.0502/19 02:43 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

The session may provide insights but lacks immediate catalysts for price movement.

How important is it?

The presentation could clarify Ginkgo's direction, influencing investor confidence moderately.

Why Short Term?

The upcoming presentation may only influence short-term investor sentiment temporarily.

Related Companies

Presentation and Q&A session scheduled for post-market on Tuesday, February 25, 2025 , /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2024, on Tuesday, February 25, 2025, beginning at 5:30 p.m. ET. The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available. To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected]. About Ginkgo Bioworks Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn. Ginkgo Bioworks Contacts: INVESTOR CONTACT: [email protected]  MEDIA CONTACT: [email protected] SOURCE Ginkgo Bioworks WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News